tradingkey.logo

Medifast Inc

MED
11.425USD
-0.425-3.59%
交易中 美東報價延遲15分鐘
125.57M總市值
499.34本益比TTM

Medifast Inc

11.425
-0.425-3.59%

關於 Medifast Inc 公司

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.

Medifast Inc簡介

公司代碼MED
公司名稱Medifast Inc
上市日期Dec 30, 1993
CEOChard (Daniel R)
員工數量504
證券類型Ordinary Share
年結日Dec 30
公司地址100 International Drive, 18th Floor
城市BALTIMORE
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編21202
電話14105818042
網址https://medifastinc.com/
公司代碼MED
上市日期Dec 30, 1993
CEOChard (Daniel R)

Medifast Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--
Mr. Ming Xian
Mr. Ming Xian
Independent Director
Independent Director
--
--
Ms. Elizabeth A. Geary
Ms. Elizabeth A. Geary
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--

收入明細

FY2025Q2
FY2025Q1
FY2024
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
105.56M
0.00%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月18日 週二
更新時間: 11月18日 週二
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
其他
69.09%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
其他
69.09%
股東類型
持股股東
佔比
Investment Advisor
34.59%
Investment Advisor/Hedge Fund
25.52%
Hedge Fund
17.51%
Research Firm
7.05%
Individual Investor
3.30%
Family Office
0.88%
Pension Fund
0.13%
Bank and Trust
0.12%
Insurance Company
0.03%
其他
10.85%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
470
8.80M
80.10%
-3.51M
2025Q2
501
8.65M
78.71%
-4.63M
2025Q1
543
8.84M
80.44%
-4.55M
2024Q4
558
9.50M
86.82%
-4.11M
2024Q3
566
9.73M
88.98%
-4.84M
2024Q2
601
11.02M
100.79%
-3.10M
2024Q1
608
12.20M
111.59%
-579.67K
2023Q4
629
10.91M
100.15%
-1.24M
2023Q3
641
10.20M
93.63%
-1.89M
2023Q2
664
10.18M
93.46%
-1.94M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
799.27K
7.27%
-56.13K
-6.56%
Jun 30, 2025
Renaissance Technologies LLC
813.31K
7.4%
-75.62K
-8.51%
Jun 30, 2025
The Vanguard Group, Inc.
795.45K
7.24%
+31.89K
+4.18%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
421.17K
3.83%
+155.60K
+58.59%
Jun 30, 2025
BofA Global Research (US)
396.37K
3.61%
+107.85K
+37.38%
Jun 30, 2025
Two Sigma Investments, LP
419.02K
3.81%
-16.70K
-3.83%
Jun 30, 2025
Acadian Asset Management LLC
411.10K
3.74%
+25.38K
+6.58%
Jun 30, 2025
Parametric Portfolio Associates LLC
323.67K
2.94%
+108.94K
+50.73%
Jun 30, 2025
AQR Capital Management, LLC
220.13K
2%
+20.38K
+10.20%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月2日 週二
更新時間: 12月2日 週二
機構名稱
佔比
Acquirers Small and Micro Deep Value ETF
0.79%
Federated Hermes MDT Small Cap Core ETF
0.19%
First Trust Active Factor Small Cap ETF
0.15%
iShares US Small Cap Value Factor ETF
0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.12%
Schwab Fundamental U.S. Small Company ETF
0.06%
iShares US Small-Cap Equity Factor ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.02%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
查看更多
Acquirers Small and Micro Deep Value ETF
佔比0.79%
Federated Hermes MDT Small Cap Core ETF
佔比0.19%
First Trust Active Factor Small Cap ETF
佔比0.15%
iShares US Small Cap Value Factor ETF
佔比0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
佔比0.12%
Schwab Fundamental U.S. Small Company ETF
佔比0.06%
iShares US Small-Cap Equity Factor ETF
佔比0.04%
Franklin US Small Cap Multifactor Index ETF
佔比0.02%
iShares Micro-Cap ETF
佔比0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.02%

分紅派息

近5年累計派現 262.40M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Sep 07, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Nov 07, 2023 going ex on Sep 18, 2023
Sep 19, 2023
Nov 07, 2023
Sep 18, 2023
Jun 15, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Aug 08, 2023 going ex on Jun 26, 2023
Jun 27, 2023
Aug 08, 2023
Jun 26, 2023
Mar 16, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on May 09, 2023 going ex on Mar 27, 2023
Mar 28, 2023
May 09, 2023
Mar 27, 2023
Dec 08, 2022
MED.NB Final Cash Dividend of gross USD 1.64 paid on Feb 07, 2023 going ex on Dec 19, 2022
Dec 20, 2022
Feb 07, 2023
Dec 19, 2022
Sep 08, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Nov 08, 2022 going ex on Sep 19, 2022
Sep 20, 2022
Nov 08, 2022
Sep 19, 2022
Jun 16, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Aug 08, 2022 going ex on Jun 27, 2022
Jun 28, 2022
Aug 08, 2022
Jun 27, 2022
Mar 17, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on May 09, 2022 going ex on Mar 28, 2022
Mar 29, 2022
May 09, 2022
Mar 28, 2022
Dec 08, 2021
MED.NB Final Cash Dividend of gross USD 1.42 paid on Feb 08, 2022 going ex on Dec 20, 2021
Dec 21, 2021
Feb 08, 2022
Dec 20, 2021
Sep 09, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Nov 08, 2021 going ex on Sep 20, 2021
Sep 21, 2021
Nov 08, 2021
Sep 20, 2021
Jun 03, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Aug 06, 2021 going ex on Jun 21, 2021
Jun 22, 2021
Aug 06, 2021
Jun 21, 2021
查看更多

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Medifast Inc的前五大股東是誰?

Medifast Inc的前五大股東如下:
BlackRock Institutional Trust Company, N.A.
持有股份:799.27K
佔總股份比例:7.27%。
Renaissance Technologies LLC
持有股份:813.31K
佔總股份比例:7.40%。
The Vanguard Group, Inc.
持有股份:795.45K
佔總股份比例:7.24%。
Charles Schwab Investment Management, Inc.
持有股份:421.17K
佔總股份比例:3.83%。
BofA Global Research (US)
持有股份:396.37K
佔總股份比例:3.61%。

Medifast Inc的前三大股東類型是什麼?

Medifast Inc 的前三大股東類型分別是:
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.

有多少機構持有Medifast Inc(MED)的股份?

截至2025Q3,共有470家機構持有Medifast Inc的股份,合計持有的股份價值約為8.80M,占公司總股份的80.10% 。與2025Q2相比,機構持股有所增加,增幅為1.39%。

哪個業務部門對Medifast Inc的收入貢獻最大?

在FY2025Q2,--業務部門對Medifast Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI